Kevin Dale Courtney
Co-Leader of the Genitourinary Oncology Disease-Oriented Team · UT Southwestern’s Harold C. Simmons Comprehensive Cancer Center
Credentials: · · ·
History
- 2005–2008
1993–2002
Research
The PI3K pathway as drug target in human cancer
Review · Journal of Clinical Oncology · 2010 · First of 3 authors · 1,037 citations
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Nature Chemical Biology · 2012 · 671 citations
Targeting renal cell carcinoma with a HIF-2 antagonist
Nature · 2016 · 626 citations
14 papers
13 papers
11 papers
11 papers
10 papers · 1 as a fellow
10 papers
10 papers
8 papers
Grants
- 2010–2031
UT Southwestern Medical Center Simmons Comprehensive Cancer Center
National Cancer Institute · P30
Project lead · $1.3M · Ut Southwestern Medical Center
- 2014–2027
North American Star Consortium
National Cancer Institute · UM1
PI · $12.9M · University Health Network
Clinical trials
- 2014–2018
Principal investigator · Completed · Phase 2
University of Texas Southwestern Medical Center
- 2025–2028
Site PI · Recruiting · Phase 2
University of Chicago
- 2024–2031
Site PI · Recruiting · Phase 3
Novartis Pharmaceuticals
- 2023–2033
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Site PI · Recruiting · Phase 4
Novartis Pharmaceuticals